Overweight Tied to Better Head, Neck Cancer Outcomes After Chemoradiotherapy
FRIDAY, June 30, 2023 (HealthDay News) — Overweight body mass index (BMI) is associated with favorable outcomes in patients with nonmetastatic head and neck cancer undergoing chemoradiotherapy, according to a study published online June 27 in JAMA Ne…
Learn MoreBulevirtide Linked to Decline in Hepatitis D Virus RNA Levels
FRIDAY, June 30, 2023 (HealthDay News) — For patients with hepatitis D virus (HDV), bulevirtide is associated with a reduction in HDV RNA levels and alanine aminotransferase (ALT) levels, according to a study published online June 22 in the New Engla…
Learn MorePegozafermin Leads to Improvements in Fibrosis in NASH
FRIDAY, June 30, 2023 (HealthDay News) — For patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH) and stage F2 or F3 fibrosis, treatment with pegozafermin leads to improvements in fibrosis, according to a study published online June 24 …
Learn MoreIntranasal Insulin May Have Pro-Cognitive Benefits
FRIDAY, June 30, 2023 (HealthDay News) — Intranasal insulin (INI) seems to have a beneficial effect on global cognition among patients with Alzheimer disease (AD)/mild cognitive impairment (MCI), according to a review published online June 28 in PLOS…
Learn MoreMeds Rarely Initiated After Discharge for Alcohol Use Disorder
FRIDAY, June 30, 2023 (HealthDay News) — Patients hospitalized for alcohol use disorder (AUD) rarely initiate medications for AUD (MAUD) after discharge, according to a research letter published online June 27 in the Annals of Internal Medicine.Eden …
Learn MoreAHA News: ¿Recibes suficientes ácidos grasos omega-3?
VIERNES, 30 de junio de 2023 (American Heart Association News) — Los ácidos grasos omega-3 juegan un papel importante en la salud cardíaca y en la cerebral. Se les ha relacionado con un sistema inmunológico más fuerte, reducción de la inflamación y n…
Learn MoreSoaring Misuse of Horse Tranquilizer Xylazine Is Worsening Opioid Crisis
FRIDAY, June 30, 2023 (HealthDay News) — Drug overdose deaths involving a powerful horse tranquilizer called xylazine have skyrocketed in the United States, rising 35-fold in just a handful of years, federal health researchers say.The number of xylaz…
Learn MoreFDA Approves First Gene Therapy for Severe Hemophilia A
FRIDAY, June 30, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Thursday approved a costly single-dose gene therapy for patients with severe hemophilia A, a life-threatening hereditary bleeding disorder.The treatment is not cheap: R…
Learn More